




Searching News Database: Mylan Laboratories
HSMN NewsFeed - 23 Jun 2012
Teva Announces Favorable Court Ruling in COPAXONE(R) Patent Infringement Litigation
Teva Announces Favorable Court Ruling in COPAXONE(R) Patent Infringement Litigation
HSMN NewsFeed - 23 Feb 2012
Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of Harry A. Korman as President, North America
Mylan Announces Appointment of Harry A. Korman as President, North America
HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Gregory L. (Greg) Sheldon as Global Chief Information Officer
Mylan Announces Appointment of Gregory L. (Greg) Sheldon as Global Chief Information Officer
HSMN NewsFeed - 14 Sep 2007
Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
HSMN NewsFeed - 10 Aug 2007
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
HSMN NewsFeed - 7 Jun 2007
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
HSMN NewsFeed - 31 May 2007
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
HSMN NewsFeed - 1 May 2007
Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
HSMN NewsFeed - 23 Apr 2007
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
HSMN NewsFeed - 18 Apr 2007
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
HSMN NewsFeed - 13 Apr 2007
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
HSMN NewsFeed - 27 Mar 2007
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
HSMN NewsFeed - 26 Mar 2007
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
HSMN NewsFeed - 23 Mar 2007
Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone
Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone
HSMN NewsFeed - 14 Mar 2007
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
HSMN NewsFeed - 26 Feb 2007
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
HSMN NewsFeed - 16 Feb 2007
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
HSMN NewsFeed - 8 Feb 2007
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
HSMN NewsFeed - 31 Jan 2007
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
HSMN NewsFeed - 31 Jan 2007
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
HSMN NewsFeed - 30 Jan 2007
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
HSMN NewsFeed - 3 Jan 2007
Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
HSMN NewsFeed - 10 Nov 2006
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
HSMN NewsFeed - 7 Sep 2006
U.S. Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent Litigation
U.S. Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent Litigation
HSMN NewsFeed - 13 Jul 2006
Mylan Announces Tentative Approval for Amlodipine Besylate and Benazepril Hydrochloride Capsules
Mylan Announces Tentative Approval for Amlodipine Besylate and Benazepril Hydrochloride Capsules
HSMN NewsFeed - 8 May 2006
PDI Announces Appointment of Michael J. Marquard as Chief Executive Officer
PDI Announces Appointment of Michael J. Marquard as Chief Executive Officer
Additional items found! 114

Members Archive contains
114 additional stories matching:
Mylan Laboratories
(Password required)
Mylan Laboratories
(Password required)